Literature DB >> 24449915

Characterization of the IL-15 niche in primary and secondary lymphoid organs in vivo.

Guangwei Cui1, Takahiro Hara, Szandor Simmons, Keisuke Wagatsuma, Akifumi Abe, Hitoshi Miyachi, Satsuki Kitano, Masaru Ishii, Shizue Tani-ichi, Koichi Ikuta.   

Abstract

IL-15 is a cytokine critical for development, maintenance, and response of T cells, natural killer (NK) cells, NK T cells, and dendritic cells. However, the identity and distribution of IL-15-expressing cells in lymphoid organs are not well understood. To address these questions, we established and analyzed IL-15-CFP knock-in mice. We found that IL-15 was highly expressed in thymic medulla, and medullary thymic epithelial cells with high MHC class II expression were the major source of IL-15. In bone marrow, IL-15 was detected primarily in VCAM-1(+)PDGFRβ(+)CD31(-)Sca-1(-) stromal cells, which corresponded to previously described CXCL12-abundant reticular cells. In lymph nodes, IL-15-expressing cells were mainly distributed in the T-cell zone and medulla. IL-15 was expressed in some fibroblastic reticular cells and gp38(-)CD31(-) double-negative stromal cells in the T-cell zone. Blood endothelial cells, including all high endothelial venules, also expressed high IL-15 levels in lymph nodes, whereas lymphatic endothelial cells (LECs) lacked IL-15 expression. In spleen, IL-15 was expressed in VCAM-1(+) stromal cells, where its expression increased as mice aged. Finally, IL-15 expression in blood and LECs of peripheral lymphoid organs significantly increased in LPS-induced inflammation. Overall, we have identified and characterized several IL-15-expressing cells in primary and secondary lymphoid organs, providing a unique perspective of IL-15 niche in immune microenvironment. This study also suggests that some stromal cells express IL-7 and IL-15 differentially and suggests a way to functionally classify different stromal cell subsets.

Entities:  

Keywords:  aging; differentiation; homeostasis; thymus

Mesh:

Substances:

Year:  2014        PMID: 24449915      PMCID: PMC3918838          DOI: 10.1073/pnas.1318281111

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

1.  Dendritic cells control lymphocyte entry to lymph nodes through high endothelial venules.

Authors:  Christine Moussion; Jean-Philippe Girard
Journal:  Nature       Date:  2011-11-13       Impact factor: 49.962

2.  CD1d-restricted NKT cells contribute to the age-associated decline of T cell immunity.

Authors:  Douglas E Faunce; Jessica L Palmer; Kelly K Paskowicz; Pamela L Witte; Elizabeth J Kovacs
Journal:  J Immunol       Date:  2005-09-01       Impact factor: 5.422

3.  Requirement for IRF-1 in the microenvironment supporting development of natural killer cells.

Authors:  K Ogasawara; S Hida; N Azimi; Y Tagaya; T Sato; T Yokochi-Fukuda; T A Waldmann; T Taniguchi; S Taki
Journal:  Nature       Date:  1998-02-12       Impact factor: 49.962

4.  Cutting edge: the role of IFN-α receptor and MyD88 signaling in induction of IL-15 expression in vivo.

Authors:  Sara L Colpitts; Thomas A Stoklasek; Courtney R Plumlee; Joshua J Obar; Caiying Guo; Leo Lefrançois
Journal:  J Immunol       Date:  2012-02-10       Impact factor: 5.422

5.  Fibroblastic reticular cells in lymph nodes regulate the homeostasis of naive T cells.

Authors:  Alexander Link; Tobias K Vogt; Stéphanie Favre; Mirjam R Britschgi; Hans Acha-Orbea; Boris Hinz; Jason G Cyster; Sanjiv A Luther
Journal:  Nat Immunol       Date:  2007-09-23       Impact factor: 25.606

6.  Activation of peripheral blood T cells by interaction and migration through endothelium: role of lymphocyte function antigen-1/intercellular adhesion molecule-1 and interleukin-15.

Authors:  D Sancho; M Yáñez-Mó; R Tejedor; F Sánchez-Madrid
Journal:  Blood       Date:  1999-02-01       Impact factor: 22.113

7.  Interleukin-7 receptor controls development and maturation of late stages of thymocyte subpopulations.

Authors:  Shizue Tani-ichi; Akihiro Shimba; Keisuke Wagatsuma; Hitoshi Miyachi; Satsuki Kitano; Kumiko Imai; Takahiro Hara; Koichi Ikuta
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-24       Impact factor: 11.205

8.  Overexpression of Interleukin-15 increases susceptibility to lipopolysaccharide-induced liver injury in mice primed with Mycobacterium bovis bacillus Calmette-Guerin.

Authors:  Toshiki Yajima; Hitoshi Nishimura; Kimika Saito; Hiroyuki Kuwano; Yasunobu Yoshikai
Journal:  Infect Immun       Date:  2004-07       Impact factor: 3.441

9.  Prospective identification, isolation, and systemic transplantation of multipotent mesenchymal stem cells in murine bone marrow.

Authors:  Satoru Morikawa; Yo Mabuchi; Yoshiaki Kubota; Yasuo Nagai; Kunimichi Niibe; Emi Hiratsu; Sadafumi Suzuki; Chikako Miyauchi-Hara; Narihito Nagoshi; Takehiko Sunabori; Shigeto Shimmura; Atsushi Miyawaki; Taneaki Nakagawa; Toshio Suda; Hideyuki Okano; Yumi Matsuzaki
Journal:  J Exp Med       Date:  2009-10-19       Impact factor: 14.307

10.  Differential effects of age on circulating and splenic leukocyte populations in C57BL/6 and BALB/c male mice.

Authors:  Lesya M Pinchuk; Nikolay M Filipov
Journal:  Immun Ageing       Date:  2008-02-11       Impact factor: 6.400

View more
  70 in total

1.  Perivascular Adventitial Fibroblast Specialization Accompanies T Cell Retention in the Inflamed Human Dermis.

Authors:  Alexander M S Barron; Julio C Mantero; Jonathan D Ho; Banafsheh Nazari; Katharine L Horback; Jag Bhawan; Robert Lafyatis; Christina Lam; Jeffrey L Browning
Journal:  J Immunol       Date:  2018-12-03       Impact factor: 5.422

2.  Interleukin-15 deficiency promotes the development of T-cell acute lymphoblastic leukemia in non-obese diabetes mice with severe combined immunodeficiency.

Authors:  D Bobbala; R Kandhi; X Chen; M Mayhue; E Bouchard; J Yan; H Knecht; F Barabé; S Ramanathan; S Ilangumaran
Journal:  Leukemia       Date:  2016-02-15       Impact factor: 11.528

Review 3.  Fibroblastic reticular cells: organization and regulation of the T lymphocyte life cycle.

Authors:  Flavian D Brown; Shannon J Turley
Journal:  J Immunol       Date:  2015-02-15       Impact factor: 5.422

4.  Myeloid cells activate iNKT cells to produce IL-4 in the thymic medulla.

Authors:  Haiguang Wang; Elise R Breed; You Jeong Lee; Lily J Qian; Stephen C Jameson; Kristin A Hogquist
Journal:  Proc Natl Acad Sci U S A       Date:  2019-10-14       Impact factor: 11.205

5.  CD4 effector T cell differentiation is controlled by IL-15 that is expressed and presented in trans.

Authors:  Adam T Waickman; Davinna L Ligons; SuJin Hwang; Joo-Young Park; Vanja Lazarevic; Noriko Sato; Changwan Hong; Jung-Hyun Park
Journal:  Cytokine       Date:  2017-08-12       Impact factor: 3.861

6.  Mechanistic Insights into CpG DNA and IL-15 Synergy in Promoting B Cell Chronic Lymphocytic Leukemia Clonal Expansion.

Authors:  Rashmi Gupta; Xiao J Yan; Jacqueline Barrientos; Jonathan E Kolitz; Steven L Allen; Kanti Rai; Nicholas Chiorazzi; Patricia K A Mongini
Journal:  J Immunol       Date:  2018-08-01       Impact factor: 5.422

7.  IL-15 promotes activation and expansion of CD8+ T cells in HIV-1 infection.

Authors:  Souheil-Antoine Younes; Michael L Freeman; Joseph C Mudd; Carey L Shive; Arnold Reynaldi; Soumya Panigrahi; Jacob D Estes; Claire Deleage; Carissa Lucero; Jodi Anderson; Timothy W Schacker; Miles P Davenport; Joseph M McCune; Peter W Hunt; Sulggi A Lee; Sergio Serrano-Villar; Robert L Debernardo; Jeffrey M Jacobson; David H Canaday; Rafick-Pierre Sekaly; Benigno Rodriguez; Scott F Sieg; Michael M Lederman
Journal:  J Clin Invest       Date:  2016-06-20       Impact factor: 14.808

Review 8.  Exploiting lymphatic vessels for immunomodulation: Rationale, opportunities, and challenges.

Authors:  Katharina Maisel; Maria Stella Sasso; Lambert Potin; Melody A Swartz
Journal:  Adv Drug Deliv Rev       Date:  2017-07-08       Impact factor: 15.470

Review 9.  Strategies for enhancing adoptive T-cell immunotherapy against solid tumors using engineered cytokine signaling and other modalities.

Authors:  Thomas Shum; Robert L Kruse; Cliona M Rooney
Journal:  Expert Opin Biol Ther       Date:  2018-05-14       Impact factor: 4.388

Review 10.  Immunotherapy: A promising approach to reverse sepsis-induced immunosuppression.

Authors:  Naeem K Patil; Julia K Bohannon; Edward R Sherwood
Journal:  Pharmacol Res       Date:  2016-07-25       Impact factor: 7.658

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.